Summary
Genable Technologies Ltd (Spark) formerly Genable Technologies Limited is a biopharmaceutical company that discovers, manufactures and distributes new gene therapies for the treatment of inherited genetic disorders. The company is developing gene based therapies for the treatment of hereditary genetic disorders. It offers GT038, which is used for the treatment of patients with inherited blindness resulting from mutations in the RHO gene. Genable has also developed rhonova, which is designed to treat rhodopsin linked autosomal dominant retinitis pigmentosa. The company has operations in the US and Europe. Genable is headquartered in Dublin, Ireland.
Genable Technologies Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Genable Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Genable Technologies Secures US$6.8 Million In Series B Financing 10
Licensing Agreements 11
Spark Therapeutics Enters Into Licensing Agreement With Genable Technologies 11
Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies 13
Acquisition 14
Spark Therapeutics Acquires Genable Technologies for USD15.2 Million 14
Genable Technologies Ltd - Key Competitors 16
Key Employees 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List of Tables
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts 1
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Genable Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Genable Technologies Ltd, Deals By Therapy Area, 2010 to YTD 2016 8
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 9
Genable Technologies Secures US$6.8 Million In Series B Financing 10
Spark Therapeutics Enters Into Licensing Agreement With Genable Technologies 11
Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies 13
Spark Therapeutics Acquires Genable Technologies for USD15.2 Million 14
Genable Technologies Ltd, Key Competitors 16
Genable Technologies Ltd, Key Employees 17
List of Figures
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Genable Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8